Knee Surgery for Torn Cartilage May Not Be Worthwhile Knee Surgery for Torn Cartilage May Not Be Worthwhile
Many middle-aged and older adults with a meniscal tear and knee pain are not likely to benefit from arthroscopic partial meniscectomy (APM), a review of past studies suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 8, 2019 Category: Consumer Health News Tags: Orthopaedics News Source Type: news
Knee surgery for torn cartilage may not be worthwhile
(Reuters Health) - Many middle-aged and older adults with torn cartilage and pain in their knee are not likely to benefit from so-called arthroscopic surgery, a review of past studies suggests. (Source: Reuters: Health)
Source: Reuters: Health - March 7, 2019 Category: Consumer Health News Tags: healthNews Source Type: news
Apollo Endosurgery touts results of stomach-stapling study
Apollo Endosurgery’s OverStitch device
Apollo Endosurgery (NSDQ:APEN) has reported key data from 1,000 patients who underwent endoscopic gastroplasty using the company’s OverStitch device.
Published in the journal Gastrointestinal Endoscopy, the data include a mean total weight loss of 14.8%±8.5% at 18 months. Three months following surgery, the impact on obesity-related comorbidities included the complete remission of:
13 of 17 cases of type 2 diabetes.
All 28 cases of hypertension.
18 of 32 cases of dyslipidemia.
Get the full story on our sister site, Medical Design & Outsourcing.
The post Apo...
Source: Mass Device - February 20, 2019 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Clinical Trials Endoscopic / Arthroscopic News Well Surgical Weight loss Apollo Endosurgery Source Type: news
Outcomes Better With Arthroscopy for Femoroacetabular Impingement Outcomes Better With Arthroscopy for Femoroacetabular Impingement
Arthroscopic hip surgery results in better outcomes than physiotherapy and activity modification in patients with symptomatic femoroacetabular impingement (FAI), according to a new clinical trial, but researchers still urge caution.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - February 16, 2019 Category: Radiology Tags: Orthopaedics News Source Type: news
FDA clears Rebound Therapeutics ’ minimally invasive neurosurgical endoscope
Rebound Therapeutics has secured FDA 510(k) clearance for its Aurora Surgiscope system, which it touts as the first single-use disposable neurosurgical endoscope.
The Aurora system enables minimally invasive access, visualization and illumination during neurosurgical procedures, the Irvine, Calif.–based company said yesterday.
“Our physician advisors specified that we enable the complete neurosurgical procedure, without reliance on any third-party component, to keep the procedure minimally invasive, simple and without expensive capital equipment,” Rebound CEO Jeffrey Valko said in a news release.
“A signif...
Source: Mass Device - January 24, 2019 Category: Medical Devices Authors: Chris Newmarker Tags: 510(k) Business/Financial News Endoscopic / Arthroscopic Neurological News Well Regulatory/Compliance Surgical reboundtherapeutics Source Type: news
J & J may nab surgical robotics company Auris Health
Johnson & Johnson (NYSE:JNJ) intends to acquire surgical robotics company Auris Health, according to a report by Bloomberg News.
In May 2018, Auris inked an agreement with J&J’s division Ethicon’s NeuWave Medical subsidiary to develop systems for the robotically-assisted bronchoscopic ablation of lung lesions. J&J has been working with Alphabet‘s (NSDQ:GOOGL) Verily Life Sciences on Verb Surgical’s prototype robot-assisted surgery platform.
J&J wants to spend more for Auris than the smaller company’s $2 billion valuation from its latest funding round, the Bloomberg report said...
Source: Mass Device - January 23, 2019 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Business/Financial News Endoscopic / Arthroscopic Mergers & Acquisitions Robotics aurishealth johnsonandjohnson Source Type: news
Smith & Nephew closes Ceterix buyout
Smith & Nephew (NYSE:SNN) said today that it completed its $50 million acquisition of Ceterix Orthopaedics and its NovoStitch Pro meniscal repair system.
The deal could bring in an additional $55 million, according to Smith & Nephew, based on financial performance.
The NovoStitch Pro device enables surgeons to repair arthroscopically horizontal, radial, complex, bucket handle and root tears, as well as vertical tears. Smith & Nephew noted that the device complements its own Fast-Fix 360 meniscal repair system, which is designed for vertical tears.
“NovoStitch Pro is an outstanding technology that address...
Source: Mass Device - January 22, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Featured Mergers & Acquisitions Orthopedics Wall Street Beat Ceterix Orthopaedics Smith & Nephew Source Type: news
Trice Medical adds $18m extension to Series C round
Trice Medical said today that it added more than $18 million to the $19 million Series C round it closed back in 2017.
Malvern, Pa.-based Trice, which makes the Mi-eye 2 and Mi-ultra orthopedic diagnostic devices, first closed its $19.3 million C round in June 2017. That tranche was led by Smith & Nephew (NYSE:SNN) and included Safeguard Scientifics (NYSE:SFE), HealthQuest Capital, BioStar Ventures and other unnamed returning investors; at that time the company reported raising a total of $40.9 million.
The $18.3 million extension announced today was led by Charter Capital Partners and the Municipal EmployeesR...
Source: Mass Device - January 14, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Featured Funding Roundup Imaging Orthopedics Wall Street Beat Safeguard Scientifics Smith & Nephew Trice Medical Source Type: news
Olympus rejiggers medical biz
Olympus (TYO:7733) last week announced its plan to rejigger its medical device business with an eye toward gaining share in the U.S. market.
The Japanese conglomerate weathered an accounting scandal in 2011 after firing its first foreign CEO, Michael Woodford, after he blew the whistle on unexplained payments worth around $1.7 billion and demanded the resignation of the former chairman and vice president. In September 2012 the company and 3 former executives pleaded guilty in Japan to cover-up charges.
By 2014 Olympus was caught up in an FDA warning about power morcellators, which were found to pose a cancer risk;...
Source: Mass Device - January 14, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Endoscopic / Arthroscopic Featured Wall Street Beat Olympus Source Type: news
2019-2020 Sports Medicine, Shoulder Reconstruction & Upper Extremity Fellowship - Cleveland Clinic Florida
The Cleveland Clinic Florida Department of Orthopedics is pleased to offer a one-year combined Sports Medicine and Upper Extremity fellowship. Our combined fellowship offers unique opportunities to the aspiring Sports Medicine/Upper Extremity surgeons. Under the supervision of Vani Sabesan, MD, Gregory Gilot, M.D., Brian Leo, M.D., Farah Tejpar, MD, and David Westerdahl, M.D, this fellowship offers an outstanding diversity of experience in all areas of sports medicine, and upper extremity joint reconstruction. Fellows will be exposed to current arthroscopic and reconstructive shoulder, elbow, hand and knee procedures, as w...
Source: Orthogate - Latest News - January 10, 2019 Category: Orthopaedics Tags: Featured Fellowship News Source Type: news
Return to work after early repair of acute traumatic rotator cuff tears - Aagaard KE, Randeblad P, Abu-Zidan FM, Lunsjo K.
BACKGROUND: Lost workdays following rotator cuff repair is not well-studied in the literature. We aimed to define the time away from work following early arthroscopic repair of acute traumatic rotator cuff tears and compare it with the recommendations of t... (Source: SafetyLit)
Source: SafetyLit - January 8, 2019 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
2019-2020 RUSH Sports Fellowship - Dr. Shane Nho
ATTN: M3s and M4s. One-year research fellowship in hip arthroscopy at high-volume, academic institution. (Source: Orthogate - Latest News)
Source: Orthogate - Latest News - January 6, 2019 Category: Orthopaedics Tags: Featured Job Opportunities News Source Type: news
Incidence of Nerve Injury After Hip Arthroscopy Incidence of Nerve Injury After Hip Arthroscopy
Nerve injuries have been reported as a potential complication of hip arthroscopy. How often do they occur?Journal of the American Academy of Orthopaedic Surgeons (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 19, 2018 Category: Consumer Health News Tags: Orthopaedics Journal Article Source Type: news
Smith & Nephew to pay up to $105m for Ceterix Orthopaedics
Smith & Nephew (NYSE:SNN) today announces that it has agreed to acquire Ceterix Orthopaedics and its NovoStitch Pro knee repair device.
The deal calls for the British orthopedics and wound care giant to put up $50 million in up-front cash, with another $55 million due over the next five years, pegged to financial performance.
Fremont, Calif.-based Ceterix’s NovoStitch Pro is designed to repair complex meniscal tears in the knee. Smith & Nephew said the device is “highly complementary” to its own Fast-Fix 360 device for vertical meniscal tears.
“NovoStitch Pro is an outstanding technology th...
Source: Mass Device - December 18, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Featured Mergers & Acquisitions Orthopedics Wall Street Beat Ceterix Orthopaedics Smith & Nephew Source Type: news
Opioids Overprescribed After Arthroscopic Meniscectomy
THURSDAY, Dec. 6, 2018 -- Prescription opioid medications are overprescribed after simple arthroscopic meniscectomy, according to a study recently published in The Journal of Bone& Joint Surgery.
Vance Gardner, M.D., from Hoag Orthopedics in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 6, 2018 Category: Pharmaceuticals Source Type: news
